Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

hsa_circ_0002980 can help stop liver cancer cells from growing and spreading.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

FGF21 can help reduce skin inflammation caused by C. acnes.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

Telocytes in silky fowl embryos develop distinct features and connections by the 20th day of incubation.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Certain microRNAs found in normal cells can effectively suppress various cancers.

IL-18 signaling helps mature Tregs move into the thymus.

Certain genetic markers on chromosome 20 are linked to hair loss in the Han Chinese from Yunnan.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

PT-20 did not significantly improve gray hair repigmentation.

Ift20 is essential for hair follicle function and skin cell movement.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.